The role of the clinical pharmacologist in the management of adverse drug reactions

Drug Safety

Volumn 24, Issue 1, 2001, Pages 1-7

  Moore, N ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

CLINICAL PHARMACOLOGY; CLINICAL TRIAL; DRUG APPROVAL; DRUG CROSS REACTIVITY; DRUG MECHANISM; DRUG MONITORING; DRUG SAFETY; HUMAN; JOB ANALYSIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TEACHING;

EID: 0035156403     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200124010-00001     Document Type: Review

References (25)

1. Incidence and costs of adverse drug reactions during hospitalisation: Computerised monitoring versus stimulated spontaneous reporting
2. Frequency and cost of serious adverse drug reactions in a department of general medicine
3. Quantitative estimation of rare adverse events which follow a biological progression: A new model applied to chronic NSAID use
4. Counting the costs of drug-related adverse events
5. Clinical pharmacology. Adverse reactions to drugs
6. Spontaneous reporting of adverse drug reactions. I: The data
7. Spontaneous reporting of adverse drug reactions. II: Uses
8. Admissions to hospital caused by adverse drug reactions: Cross sectional incidence study. French Pharmacovigilance Centres
9. Iatrogenic medication: Estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance
10. Prescribing for older patients: How to avoid toxic drug reactions
11. Hospitalisation for adverse events related to drug therapy: Incidence, avoidability and costs
12. Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice
13. European network for the case-population surveillance of rare diseases (Euronet). A prospective feasibility study
14. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators
15. The definition and scope of clinical pharmacology
16. A regional center for reporting adverse drug reactions in Umea. Prompt handling results in quick feedback
17. Drug information and prescription guidance: Role of regional centers of pharmacovigilance
18. Pharmacovigilance: Education and continuing updating. The role of university institutes
19. Regional drug information service
20. The regional drug-therapy consultation service centre - A conception that has been serving patients and physicians alike for 30 years in Magdeburg (Germany)
21. Adverse drug reaction monitoring in Jena - Experiences of a regionalized pharmacovigilance centre
22. Adverse drug reaction monitoring: Doing it the French way
23. The Spanish drug surveillance system
24. Spontaneous reporting systems outside the United States